CSIMarket
 
Alcon inc   (NYSE: ALC)
Other Ticker:  
 
 
Price: $87.3600 $-0.48 -0.546%
Day's High: $87.82 Week Perf: 1.59 %
Day's Low: $ 87.20 30 Day Perf: -6.34 %
Volume (M): 606 52 Wk High: $ 101.10
Volume (M$): $ 52,902 52 Wk Avg: $87.04
Open: $87.77 52 Wk Low: $72.05



 Market Capitalization (Millions $) 43,374
 Shares Outstanding (Millions) 497
 Employees -
 Revenues (TTM) (Millions $) 9,455
 Net Income (TTM) (Millions $) 974
 Cash Flow (TTM) (Millions $) 980
 Capital Exp. (TTM) (Millions $) 658

Alcon Inc
Alcon Inc., also known as Alcon Laboratories, is a global pharmaceutical company specializing in eye care products and devices. Founded in 1945 and headquartered in Fort Worth, Texas, Alcon is a subsidiary of Swiss multinational Novartis. The company develops and manufactures a wide range of products including contact lenses, surgical equipment, ophthalmic pharmaceuticals, and eye care solutions. Alcon operates in over 70 countries worldwide and is committed to improving eyesight and delivering innovative solutions for patients and healthcare professionals.


   Company Address: Rue Louis-d Affry 6 Fribourg 1701
   Company Phone Number: 293 0450   Stock Exchange / Ticker: NYSE ALC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BLCO        1.91% 
COO        1.91% 
EYE        1.91% 
MASI        1.91% 
WRBY        1.91% 
WST        1.91% 
• View Complete Report
   



Alcon Inc

Underperforming in Revenue Growth raises Concerns for Alcon Inc During Fourth Quarter Earnings Report


Alcon Inc, a leading Medical Equipment & Supplies company, recently reported its financial results for the period ending December 31, 2023. While the company showcased some impressive numbers, a closer analysis reveals several potential concerns that should give investors pause.
Firstly, although Alcon Inc boasted an 8.466% increase in revenue to $9.46 billion compared to the previous year, it is crucial to consider the context. The Medical Equipment & Supplies industry as a whole only experienced a revenue growth of 8.27% during the same period. This indicates that Alcon Inc has actually been underperforming its peers. While an increase in revenue is typically seen as positive, it is concerning that Alcon Inc has not been able to match the industry average.







Alcon Inc's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com